PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0020538|hypertension |
| Sentences | 140 |
| PubMedID- 22470194 | Nafld is usually part of the metabolic syndrome, found namely in patients with diabetes mellitus, hypertension, dyslipidemia, obesity and insulin resistance, which is becoming very frequent in western populations, due to their life style (sedentariness) and diet. |
| PubMedID- 23351121 | Concurrent participants will also perform a 24-hour ambulatory blood pressure monitor in their second year of the study to assess the presence of hypertension or pre-hypertension associated with nephrotic syndrome [50]. |
| PubMedID- 23835112 | Sixty-six african-american subjects with stage 1 and 2 hypertension and characteristics of the metabolic syndrome were treated in open-label, active comparator fashion for 20 weeks. |
| PubMedID- PMC3113071 | Hyperglycemia, insulin resistance, hyperlipidemia and hypertension, which are components of metabolic syndrome, are also recognized as strong risk factors for cardiovascular disease [1]. |
| PubMedID- 25875942 | Non-alcoholic fatty liver disease (nafld) is the most common cause of hepatic disease in western civilization [1] and is considered as a hepatic manifestation of a metabolic syndrome strongly associated with dyslipidemia, obesity, hypertension and insulin resistance[2]. |
| PubMedID- 21773016 | In addition, there is mounting evidence that chronic psychological stress and negative mood states are strongly associated, in a bidirectional manner, with insulin resistance, glucose intolerance, central obesity, dyslipidemia, hypertension, and other components of the metabolic syndrome [19–25]. |
| PubMedID- 20795419 | Metabolic syndrome in patients with hypertension attending a family practice clinic in jordan. |
| PubMedID- 25760026 | Metabolic detuning has been reported to be involved in obesity, dyslipidemia, diabetesmellitus, and hypertension, all of which characterize metabolic syndrome and are closelyassociated with insulin resistance. |
| PubMedID- 21644841 | The enhanced effect of atenolol on hypertension in metabolic syndrome. |
| PubMedID- 20813031 | Our aim is to estimate the epidemiological and economic burden to the health service of metabolic syndrome in patients with hypertension in three european countries in 2008 and 2020. |
| PubMedID- 20718958 | The possible mechanisms that trigger arterial hypertension associated with metabolic syndrome are mainly related to the presence of visceral fat, which results in insulin resistance. |
| PubMedID- 24958506 | Role of nitric oxide synthase uncoupling at rostral ventrolateral medulla in redox-sensitive hypertension associated with metabolic syndrome. |
| PubMedID- 22448351 | Pecularities of prolonged use of moxonidine in patients with hypertension associated with metabolic syndrome. |
| PubMedID- 21471972 | Inefficient arterial hypertension control in patients with metabolic syndrome and its link to renin-angiotensin-aldosterone system polymorphisms. |
| PubMedID- 21659755 | There is considerable evidence that obesity, hypertension and other elements of the metabolic syndrome also contribute to the progression of renal disease independent of diabetes. |
| PubMedID- 22963383 | We describe a rat model for maladaptive cardiac remodeling in obesity and metabolic syndrome associated with hypertension, a common comorbid condition, gaining increasing relevance. |
| PubMedID- 24467657 | These results suggest that increases in atp content in rvlm is engaged in the augmented sympathetic vasomotor activity and hypertension associated with metabolic syndrome induced by the hfd. |
| PubMedID- 21286276 | Ameliorating “renal leptin resistance” or reducing leptin level and/or leptin signaling in states of chronic hyperleptinemia may be a novel strategy for the treatment of arterial hypertension associated with the metabolic syndrome. |
| PubMedID- 24048967 | Also glucose intolerance and hypertension, both part of the metabolic syndrome, were evident in the gc-treated mice. |
| PubMedID- 24466463 | hypertension is a component of metabolic syndrome, and interestingly, certain aldh2 genotypes have also been proposed as risk factors for metabolic syndrome with liver dysfunction [5]. |
| PubMedID- 26276551 | The nafld group was characterized by a higher bmi, whr, arterial hypertension and higher prevalence of metabolic syndrome according to atpiii criteria (p < 0.001). |
| PubMedID- 23586038 | The leptin receptor deficient spontaneously hypertensive rat (shr-cp) is a well-established model of metabolic syndrome with hypertension, dyslipidemia, insulin resistance, and obesity [25–27]. |
| PubMedID- 22534714 | Obesity and arterial hypertension are both components of metabolic syndrome; moreover, adipose tissue is considered to be a potent hypertensive agent. |
| PubMedID- 23375154 | Studies have shown that fibrinogen is associated with diabetes regulation, age, hypertension and components of the metabolic syndrome [17,18]. |
| PubMedID- 21390196 | Fifty nine had isolated metabolic syndrome (group a) and 97 had metabolic syndrome with hypertension and/or diabetes (group b). |
| PubMedID- 26073101 | Arterial hypertension in children with hemolytic uremic syndrome after kidney transplantation. |
| PubMedID- 25906108 | hypertension, a component of the metabolic syndrome, was indicated to be associated with prostate cancer.17,43,44 however, not all epidemiological studies have supported this link.12,13 in this study, more prostate patients were observed in the hypertension group, but the difference did not reach the statistically significant level (adjusted hr = 1.20, 95% ci = 0.97–1.47). |
| PubMedID- 24410986 | All components of metabolic syndrome, including hypertension [4,5], insulin resistance(ir) [6,7], and low hdl-c, together with high levels of tg [8,9] are frequent in patients with osas. |
| PubMedID- 23173592 | Clinical and experimental studies have assessed the relationship between hyperuricemia and hypertension in the context of metabolic syndrome (regardless of the visceral obesity component this time). |
| PubMedID- 25615826 | Medical costs for people with obesity are approximately 30% greater than for people with normal weights, because obesity is related to serious health problems such as diabetes, hypertension, and other components of metabolic syndrome [3]. |
| PubMedID- 23629805 | Thus, shrcp are regarded as a useful model of human hypertension with metabolic syndrome. |
| PubMedID- 24051520 | Effectiveness of bosentan in a case of pulmonary arterial hypertension associated with myelodysplastic syndrome. |
| PubMedID- 24729809 | All parameters of metabolic syndrome with resolving/improving t2dm, hypertension, joint disease, depressive disorders or sleep apnoea are normalized or markedly improved after lsg. |
| PubMedID- 23690769 | Medical complications of obesity in the elderly are mainly concentrated around the metabolic syndrome (with glucose intolerance, hypertension, dyslipidaemia, and cardiovascular disease). |
| PubMedID- 23757400 | Shrs are a model of human essential hypertension with features of metabolic syndrome, including impaired glucose metabolism. |
| PubMedID- 22995975 | These treatments appear to be far less effective in preventing post-thrombotic syndrome (pts), associated with venous hypertension, residual occlusion, and with reflux caused by valve incompetence. |
| PubMedID- 24288531 | Sympathetic nervous system overactivity is a key mechanism leading to hypertension in patients with the metabolic syndrome. |
| PubMedID- 22471437 | A 41-year-old man was admitted for evaluation of nephrotic syndrome associated with microhematuria, hypertension, and moderate renal failure. |
| PubMedID- 22473401 | Metabolic syndrome was significantly associated with hypertension, insulin resistance, increased abdominal fat, and overweight. |
| PubMedID- 21909069 | About 6% of patients develop hypertension due to renovascular diseases, mid-aortic syndrome, or pheochromocytoma. |
| PubMedID- 20405160 | The presence of metabolic syndrome in patients with hypertension significantly increases the risk of cardiovascular disease, type 2 diabetes and mortality. |
| PubMedID- 25245490 | However, it appears to be a risk factor for early onset hypertension in metabolic syndrome. |
| PubMedID- 22866890 | The hfcd-fed sd rats developed a severe metabolic syndrome consistent with hypertension and hypercholesterolemia[18,19]. |
| PubMedID- 20556204 | Ldl-c, triglycerides, uric acid, bmi, serum glucose, metabolic syndrome, smoking, hypertension and prehypertension),[46, 47, 49] some of which are commonly found in patients with pbc. |
| PubMedID- 23835856 | Conclusions: in this study, children's hypertension was a component of the metabolic syndrome, but uric acid and hscrp levels were not contributive. |
| PubMedID- 26273620 | It can be accompanied by a number of comorbidities, including metabolic syndrome with arterial hypertension, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease (nafld) or steatohepatitis (nash) [1]. |
| PubMedID- 20880339 | Although traditional anti-diabetes agents improve hyperglycaemia, they do so at a cost, which may entail hypoglycemia and increased body weight; exacerbating dyslipidemia, hypertension and components of insulin resistance and metabolic syndrome associated with t2dm-potentially increasing cardiovascular risk. |
| PubMedID- 25993638 | Increased cardiovascular mortality in subjects with metabolic syndrome is largely attributable to diabetes and hypertension in 159,971 korean adults. |
| PubMedID- 23862060 | Also, in animal models, they have been implicated in hypertension and in components of the metabolic syndrome. |
| PubMedID- 23974905 | Thus, rd seems to be a useful therapeutic strategy for hypertension with metabolic syndrome. |